Elderly mice suffering from age-related heart disease saw a significant improvement in cardiac function after being treated with the FDA-approved drug rapamycin for just three months.
The research, led by a team of scientists at the Buck Institute for Research on Aging, shows how rapamycin impacts mammalian tissues, providing functional insights and possible benefits for a drug that has been shown to extend the lifespan of mice as much as 14 percent. There are implications for human health in the research appearing online in Aging Cell: heart disease is the leading cause of death in the U.S., claiming nearly 600,000 lives per year.
Rapamycin is an immunosuppressant drug which can be used to help prevent organ rejection after transplantation. It is also included in treatment regimens for some cancers. In this study, rapamycin was added to the diets of mice that were 24 months old – the human equivalent of 70 to 75 years of age. Similar to humans, the aged mice exhibited enlarged hearts, a general thickening of the heart wall and a reduced efficiency in the hearts ability to pump blood.
The mice were examined with ultrasound echocardiography before and after the three-month treatment period – using metrics closely paralleling those used in humans. Buck Institute faculty Simon Melov, PhD, the senior author of the study, said age-related cardiac dysfunction was either slowed or reversed in the treated mice. “When we measured the efficiency of how the heart pumps blood, the treated mice showed a remarkable improvement from where they started. In contrast, the untreated mice saw a general decline in pumping efficiency at the end of the same three month period,” he said. “This study provides the first evidence that age-related heart dysfunction can be improved even in late life via appropriate drug treatment,” added Melov, who said the treated mice saw a reduction in heart size, reduced stress signaling in heart tissues and a reduction in inflammation.
Buck researchers, utilizing genome analysis tools, uncovered suites of related genes which rapamycin modulates in the heart. “Rapamycin affected the expression of genes involved in calcium regulation, mitochondrial metabolism, hypertrophy and inflammation,” said Melov. “We also carried out behavioral assessments which showed the treated mice spent more time on running wheels than the mice who aged without intervention.”
“Little has been known about the functional ramifications of rapamycin in mammalian tissues,” said Buck Institute President and CEO Brian Kennedy, PhD, a co-author of the paper. “These findings are significant because we have no interest in simply extending lifespan without an accompanying improvement in the health and quality of life.” He added, “It is particularly encouraging that, in this case, an already-approved drug that extends lifespan also improved function late in life.”
The Latest Bing News on:
Age-Related Heart Disease
- More than one alcoholic drink a day raises heart disease risk for womenon March 28, 2024 at 6:56 am
The link between alcohol and coronary heart disease proved to be especially strong among women, new research showed.
- Multiomic approach boosts disease prediction accuracy beyond traditional methodson March 26, 2024 at 8:41 pm
Study highlights the significant enhancement in predicting common diseases like heart disease, diabetes, Alzheimer's, and prostate cancer by integrating polygenic risk scores (PRSs) and gut microbiome ...
- Coronary Heart Disease and Pregnancyon March 26, 2024 at 5:00 pm
Since women are delaying childbearing until older age, acute coronary syndrome ... the available information about pregnancy-related coronary heart disease. Yusuf Karamermer, Thorax Center ...
- 20 Countries with the Highest Heart Disease Deaths Per Capitaon March 26, 2024 at 4:20 am
In this article, we will be taking a look at the 20 countries with the highest disease deaths per capita. If you do not want to learn about the global heart disease landscape, head straight to the 5 ...
- Middle age's hidden perils — and possibilities — for the aging brainon March 23, 2024 at 3:53 am
Middle age is a tipping point for the brain and can offer clues about the risk of cognitive decline and dementia, emerging scientific evidence shows. Why it matters: The decades between 40 and 60 ...
- P.E. Teacher, 23, 'Felt Something Was Wrong' After First Marathon, Learns He Has Heart Disease a Week Later (Exclusive)on March 12, 2024 at 1:14 pm
“I was diagnosed with heart disease and had to have my heart procedure. I lived in fear the next month and a half to two months. I had so much fear, like, oh my goodness, I'm so young,” he recall ...
- The next breakthrough for longevity obsessives: measuring organ ageon March 10, 2024 at 3:51 pm
The study found that individuals with accelerated heart aging, for example ... to know they might arguably get a particular age-related disease early unless there are preventive steps or other ...
- Lupus and Heart Diseaseon March 7, 2024 at 4:00 pm
The risk of heart disease is much higher in people with lupus than in those without it. More than half of patients with SLE will get cardiovascular conditions related to their lupus. These include ...
- What Is Heart Disease? Symptoms, Causes, Diagnosis, Treatment, and Preventionon March 5, 2024 at 4:00 pm
Sometimes, structural heart defects can occur in adults as the heart’s structure changes with age. Researchers ... is closely related to heart disease, too. These episodes cause the sleeper ...
The Latest Google Headlines on:
Age-Related Heart Disease
[google_news title=”” keyword=”Age-Related Heart Disease” num_posts=”10″ blurb_length=”0″ show_thumb=”left”]
The Latest Bing News on:
Rapamycin
- Study Reveals Common Autism Mechanisms and Potential Treatment Targetson March 27, 2024 at 9:17 am
An analysis of how brains with different forms of autism develop has revealed common underlying mechanisms that may respond to existing medications.
- Can we really live forever?on March 26, 2024 at 4:00 am
In an age of remarkable scientific advances, three new books explore the prospects for living longer — and the challenges for human society ...
- Mammalian Target of Rapamycin: Biological Function and Target for Novel Anticancer Agentson March 24, 2024 at 5:00 pm
Purpose. The biological function of the mammalian target of rapamycin (mTOR) and mechanisms of action of mTOR inhibitors currently available for clinical use are described. Summary. mTOR is a ...
- How a cheap, generic drug became a darling of longevity enthusiastson March 15, 2024 at 11:56 am
Rapamycin, a drug for transplant patients, has extended the lives of animals but is unproven in humans. That hasn’t stopped people from trying it.
- Tech moguls and longevity gurus are using a $2 organ transplant pill to reverse AGINGon March 15, 2024 at 8:50 am
Rapamycin - which costs around $2.30 per pill - has become the latest obsession among longevity experts and biohackers who say it can slow down the aging process. Despite a lack of evidence that ...
- How a cheap, generic drug became a darling of longevity enthusiastson March 14, 2024 at 5:00 pm
Rapamycin was collected by a scientific expedition in the 1960s from the soil of Easter Island, also known as Rapa Nui, one of the most remote inhabited places on earth.
- Anti-ageing drug rapamycin improves immune function through endolysosomeson February 28, 2024 at 12:53 pm
Rapamycin is one of the most promising anti-ageing substances to date. Rapamycin is named after "Rapa Nui", the local translation for the Easter Islands, where the active ingredient was discovered ...
- Anti-aging drug rapamycin found to improve immune function through endolysosomeson February 27, 2024 at 4:00 pm
Rapamycin is one of the most promising anti-aging substances to date. Rapamycin is named after "Rapa Nui," the local translation for the Easter Islands, where the active ingredient was discovered ...
- Rapamycin's Anti-Aging Effects Have Scientists Calling It the 'Longevity Drug'on August 1, 2023 at 3:21 pm
Scientists are looking at a cancer drug called rapamycin and its potential to slow down aging. A growing number of animal studies have shown evidence of rapamycin extending the average lifespan ...
- Mammalian Target of Rapamycin: Biological Function and Target for Novel Anticancer Agentson February 5, 2022 at 4:49 pm
2010;67(24):2095-2106. The second mTOR complex, mTORC2, contains mTOR, mLST8, and several unique proteins, including rictor (rapamycin-insensitive companion of mTOR). Rapamycin and its analogues ...
The Latest Google Headlines on:
Rapamycin
[google_news title=”” keyword=”rapamycin ” num_posts=”10″ blurb_length=”0″ show_thumb=”left”]